Microcirculation and mitochondria in sepsis: Getting out of breath

Current Opinion in Anaesthesiology

Volumn 22, Issue 2, 2009, Pages 184-190

  Balestra, Gianmarco M ^a,b   Legrand, Matthieu ^a,c   Ince, Can ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Microcirculation; Mitochondria; Outcome; Sepsis

Indexed keywords

6 [N (2 CHLORO 4 FLUOROPHENYL)SULFAMOYL] 1 CYCLOHEXENE 1 CARBOXYLIC ACID ETHYL ESTER; ACTIVATED PROTEIN C; ADRENALIN; ARGININE; CYTOCHROME C; DOBUTAMINE; ERITORAN; ERYTHROPOIETIN; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; INSULIN; LEVOSIMENDAN; MILRINONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NORADRENALIN; TAUROLIDINE;

CELL COMPARTMENTALIZATION; CELL HETEROGENEITY; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; EVOLUTION; HOST PATHOGEN INTERACTION; HUMAN; MICROCIRCULATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK;

CAPILLARY PERMEABILITY; CARDIOVASCULAR AGENTS; CYTOCHROMES C; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MICROCIRCULATION; MITOCHONDRIA; MITOCHONDRIAL DISEASES; POLY ADENOSINE DIPHOSPHATE RIBOSE; SEPSIS;

EID: 68049089963     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328328d31a     Document Type: Review

References (72)

1. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34:344-353.
2. Freelander SO, Lenhart CH. Clinical observations on the capillary circulation. Arch Intern Med 1922; 29:12-32.
3. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005; 9 (Suppl 4):S13-S19.
4. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29:530-538.
5. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004; 8:462-468.
6. Bagshaw SM, Brophy PD, Cruz D, Ronco C. Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care 2008; 12:169.
7. Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928-1948.
8. Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74. On the basis of the SOAP cohort, this study proposes the concept of the detrimental effect of a positive fluid balance, especially if the critically ill patient suffers from acute kidney failure.
9. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121:2115-2122.
10. Furst R, Bubik MF, Bihari P, et al. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo. Mol Pharmacol 2008; 74:1-8.
11. Ladetzki-Baehs K, Keller M, Kiemer AK, et al. Atrial natriuretic peptide, a regulator of nuclear factor-kappaB activation in vivo. Endocrinology 2007; 148:332-336.
12. Morgenthaler NG, Struck J, Christ-Crain M, et al. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 2005; 9:R37-R45.
13. Meyer B, Huelsmann M, Wexberg P, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007; 35:2268-2273.
14. Boerma EC, van der Voort PH, Spronk PE, Ince C. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 2007; 35:1055-1060.
15. Melican K, Boekel J, Mansson LE, et al. Bacterial infection-mediated mucosal signalling induces local renal ischaemia as a defence against sepsis. Cell Microbiol 2008; 10:1987-1998. An elegant study that provides significant insights into the pathophysiology of ascending urinary tract infection. The authors demonstrate how the systemic spread of the infection is prevented by a shutdown of the microcirculation. Prevention of microcirculatory flow deterioration by anticoagulation led to fatal urosepsis.
16. Annane D, Sanquer S, Sébille V, et al. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000; 355:1143-1148.
17. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223.
18. Fredriksson K, Hammarqvist F, Strigard K, et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006; 291:E1044-E1050.
19. Giulivi C, Kato K, Cooper CE. Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology. Am J Physiol Cell Physiol 2006; 291:C1225-C1231.
20. Cooper CE, Giulivi C. Nitric oxide regulation of mitochondrial oxygen consumption II: molecular mechanism and tissue physiology. Am J Physiol Cell Physiol 2007; 292:C1993-C2003. A small review series that summarizes, in a well organized way, the relationship between nitric oxide and mitochondrial respiration. Current knowledge regarding the inhibition of oxygen consumption is described. Spatial and temporal effects are explained, as are their subjacent mechanisms.
21. Levy RJ, Vijayasarathy C, Raj NR, et al. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 2004; 21:110-114.
22. Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 2007; 35:S441-S448. This review discusses the role of mitochondrial dysfunction in the pathogenesis of multiple organ failure by examining the findings of experimental and clinical studies. The equilibrium of ATP supply and demand in sepsis is evoked, leading to the concept of a hibernation-like state characterized by decreased mitochondrial function.
23. Porta F, Takala J, Weikert C, et al. Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function. Crit Care 2006; 10:R118.
24. Goedhart PT, Khalilzada M, Bezemer R, et al. Sidestream dark field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express 2007; 15:15101-15114.
25. De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007; 11:R101. A consensus paper on the standards required for the evaluation of microcirculatory images.
26. Creteur J, Carollo T, Soldati G, et al. The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007; 33:1549-1556.
27. Doerschug KC, Delsing AS, Schmidt GA, Haynes WG. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007; 293:H1065-H1071.
28. Pareznik R, Knezevic R, Voga G, Podbregar M. Changes in muscle tissue oxygenation during stagnant ischemia in septic patients. Intensive Care Med 2006; 32:87-92.
29. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
30. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock - 2008. Crit Care Med 2008; 36:296-327.
31. Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007; 35:2016-2024.
32. Monnet X, Rienzo M, Osman D, et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 2006; 34:1402-1407.
33. Pottecher J, Deruddre S, Georger JF, et al. Both passive leg raising and volume expansion improve sublingual microcirculation in preload-dependent septic patients. Intensive Care Med 2008; 34 (Suppl 1):S103.
34. Luengo C, Losser MR, Legrand M, et al. Fluid resuscitation improves sublingual microcirculatory flow in septic shock patients. Intensive Care Med 2008; 34 (Suppl 1):S103.
35. Trzeciak S, McCoy JV, Phillip DR, et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multiorgan failure at 24 h in patients with sepsis. Intensive Care Med 2008; 34:2210-2217. In an EGDT setting, increased microcirculatory flow during resuscitation was associated with reduced organ failure at 24 h, without substantial differences in global hemodynamics. The authors conclude that these findings support the hypothesis that targeting the microcirculation distinct from the macrocirculation could potentially improve organ failure in sepsis.
36. Sennoun N, Monternont C, Gibot S, et al. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 2007; 35:1736-1740. The authors conclude that early use of norepinephrine might lead to a decreased need for fluid resuscitation while providing better tissue oxygenation and mesenteric flow. This study shows that different EGDT designs might be of interest.
37. Krejci V, Hiltebrand LB, Sigurdsson GH. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 2006; 34:1456-1463.
38. Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Increasing renal blood flow: low-dose dopamine or medium-dose norepinephrine. Chest 2004; 125:2260-2267.
39. Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med 2003; 31:2509-2513.
40. Duranteau J, Sitbon P, Teboul JL, et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999; 27:893-900.
41. Nakajima Y, Baudry N, Duranteau J, Vicaut E. Effects of vasopressin, norepinephrine, and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med 2006; 34:1752-1757.
42. Regueira T, Banziger B, Djafarzadeh S, et al. Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration. Crit Care 2008; 12:R88.
43. Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370:676-684.
44. Pinto BB, Rehberg S, Ertmer C, Westphal M. Role of levosimendan in sepsis and septic shock. Curr Opin Anaesthesiol 2008; 21:168-177.
45. Fries M, Ince C, Rossaint R, et al. Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. Crit Care Med 2008; 36:1886-1891.
46. Rehberg S, Ertmer C, Lange M, et al. Combined levosimendan and vasopressin prolongs survival in ovine septic shock. Crit Care Med 2007; 35:A61.
47. Spronk PE, Ince C, Gardien MJ, et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396.
48. Lamontagne F, Meade M, Ondiveeran HK, et al. Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical data. Shock 2008; 30:653-659.
49. Marti-Carvajal A, Salanti G, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev 2008:CD004388.
50. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109:3161-3172. An excellent review highlighting the different pathways modulated by APC.
51. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29:572-576.
52. Hoffmann JN, Vollmar B, Laschke MW, et al. Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 2004; 32:1011-1017.
53. Favory R, Lancel S, Marechal X, et al. Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 2006; 32:899-905.
54. Gierer P, Hoffmann JN, Mahr F, et al. Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxemia. Crit Care Med 2007; 35:1966-1971.
55. Gupta A, Berg DT, Gerlitz B, et al. Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol 2007; 18:860-867. A very nicely conducted study and one of the rare experimental studies assessing late APC administration (10 h after CLP). APC treatment reduced blood urea nitrogen, renal disorder, and chemokine expression and dramatically reduced induction of inducible nitric oxide synthase and caspase-3 activation in the kidney.
56. De Backer D, Verdant C, Chierego M, et al. Effects of drotrecogin alfa activated on micro circulatory alterations in patients with severe sepsis. Crit Care Med 2006; 34:1918-1924.
57. Regnault V, Levy B. Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy? Crit Care 2007; 11:103.
58. Thiemermann C. Beneficial effects of erythropoietin in preclinical models of shock and organ failure. Crit Care 2007; 11:132.
59. Mitra A, Bansal S, Wang W, et al. Erythropoietin ameliorates renal dysfunction during endotoxaemia. Nephrol Dial Transplant 2007; 22:2349-2353.
60. Kao R, Xenocostas A, Rui T, et al. Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Crit Care 2007; 11:R58. This study approaches a clinical, realistic setting by choosing to administer EPO 18 h after CLP. The observation of parallel recovery of microcirculatory and mitochondrial function suggests a cause-effect relationship. However, further investigations are required for confirmation.
61. Cuzzocrea S, Di Paola R, Mazzon E, et al. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 2006; 34:1168-1177.
62. Gero D, Szabo C. Poly(ADP-ribose) polymerase: a new therapeutic target? Curr Opin Anaesthesiol 2008; 21:111-121.
63. Roesner JP, Vagts DA, Iber T, et al. Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats. Intensive Care Med 2006; 32:1649-1657.
64. Szijarto A, Batmunkh E, Hahn O, et al. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status. J Surg Res 2007; 142:72-80.
65. Szabo A, Salzman AL, Szabo C. Poly (ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock. Life Sci 1998; 63:2133-2139.
66. Horvath EM, Benko R, Gero D, et al. Treatment with insulin inhibits poly(ADP-ribose) polymerase activation in a rat model of endotoxemia. Life Sci 2008; 82:205-209.
67. Piel DA, Gruber PJ, Weinheimer CJ, et al. Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med 2007; 35:2120-2127.
68. Piel DA, Deutschman CS, Levy RJ. Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 2008; 29:612-616. By using an innovative approach, the authors directly target mitochondrial dysfunction and show that mitochondrial activity can be recovered, leading to better myocardial function and survival.
69. Gao H, Evans TW, Finney SJ. Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter? Crit Care 2008; 12:213.
70. Mullarkey M, Rose JR, Bristol J, et al. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 2003; 304:1093-1102.
71. Frieling H, Lauer KS, Grundling M, et al. Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia. Int J Colorectal Dis 2007; 22:807-817.
72. Sha T, Sunamoto M, Kitazaki T, et al. Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol 2007; 571:231-239.